Clinical Trials Sponsored by Peter Siesjö

Total 408 results

Peter Siesjö

Withdrawn

Anti-secretory Factor as a Treatment for Adults With Severe Traumatic Head Injury (SATSWEDEN)

Head Trauma | Intensive Care Neurological Disorder | Edema Brain
Peter Siesjö
Lund University

Recruiting

Antisecretory Factor Glioblastoma Phase 2 (AFGB2)

Glioblastoma

Sweden
Peter Siesjö
Skane University Hospital; Lantmannen Medical AB

Recruiting

Antisecretory Factor In Severe Traumatic Brain Injury (AFISTBI)

Traumatic Brain Injury

Sweden
Peter Siesjö
University of Stellenbosch

Completed

Effect of Antisecretory Factor, Given as a Food Supplement to Adult Patients With Severe Traumatic Brain Injury (SASAT)

Brain Trauma

South Africa
Peter Siesjö
Lund University; Region Skane; Skane University Hospital; Lantmannen Medical AB

Completed

Antisecretory Factor in Primary Glioblastoma 1 (AFGBM1)

Glioblastoma | Chemotherapy Effect | Cerebral Edema

Sweden
Peter G Mavrelis

Completed

GERD Treatment With Transoral Incisionless Fundoplication (TIF) Following Hiatal Hernia Surgery (GERD)

Gastro Esophageal Reflux

United States
Peter Brehm GmbH

Terminated

Prospective Post Market Clinical Follow-Up of the Primary Knee Endoprosthesis BPK-S Integration

Osteoarthritis, Knee | Joint Instability

Austria
Anguria, Peter, M.D.

Completed

Determinants of Pterygium Occurrence and Recurrence in a Rural African Population

Pterygium

South Africa
Siesta Medical, Inc.

Terminated

FAST as a Treatment for Obstructive Sleep Apnea (FAST)

Obstructive Sleep Apnea

United States
Peter Hovind

Not yet recruiting

Assessing Repeatability and Intra-individual Variability in [O15]H2O-PET Myocardial Perfusion Imaging (Heart-Wave)

Myocardial Blood Flow

Denmark
Peter Gillgren

Completed

Trial of Surgical Excision Margins in Thick Primary Melanoma - 2

Melanoma | Surgery | Treatment Outcome
Peter Kristensen

Recruiting

DIAbetes TEam and Cgm in Managing Hospitalised Patients With Diabetes (DIATEC)

Diabetes Mellitus, Type 2

Denmark
Peter atef

Recruiting

Portal Vein Flow Velocity as a Screening Tool for Oesophageal Varices in Cirrhotic Patients (Portalflow)

Cirrhosis Portal

Egypt
Peter Nymberg

Withdrawn

Equine Assisted Services in Children and Adolescents With Mental Illness (EASiCAM)

Depression | Anorexia Nervosa | Anxiety Disorders | Anxiety | Mental Disorder in Adolescence | Mental Disorders, Child | School Fear

Sweden
Peter Lommer

Completed

The Impact of ROTO Track® in Helping Patients With Diabetes Rotate Their Insulin Injections Better (ROTOone)

Diabetes

Denmark
Peter Studinger

Suspended

Bioimpedance Analysis in Chronic Heart Failure

Heart Failure

Hungary
Peter Moosmann
Kantonsspital Aarau

Completed

Bendamustine and Bortezomib Combination Therapy in Indolent Non-Hodgkin's Lymphoma(NHL)

Lymphoma, Non-Hodgkin
Peter Humaidan

Recruiting

The Correlation Between Luteal Serum Progesterone and Live Birth Rate

Infertility

Denmark
Peter MacCallum Cancer Centre, Australia

Recruiting

Hepatocellular Carcinoma Imaging Using PSMA PET/CT (HepaSMART)

Hepatocellular Carcinoma

Australia
Peter Busch Østergren

Recruiting

National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients (Oligomet_DK)

Prostate Cancer Metastatic

Denmark
Peter MacCallum Cancer Centre, Australia

Recruiting

Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma (LEVERAGE)

Follicular Lymphoma

United States, Australia
Peter MacCallum Cancer Centre, Australia

Suspended

Pidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer (REPAIR)

Metastatic Castration Resistant Prostate Cancer (mCRPC)

Australia
Peter MacCallum Cancer Centre, Australia

Active, not recruiting

A Phase II Study to Determine Pembrolizumab as Frontline Treatment of Patients With Hodgkin Lymphoma (PLIMATH)

Hodgkin Lymphoma

Australia, New Zealand
Peter MacCallum Cancer Centre, Australia

Active, not recruiting

ABT-199 & Ibrutinib in Mantle Cell Lymphoma (AIM) (AIM)

Mantle Cell Lymphoma

Australia
Peter MacCallum Cancer Centre, Australia

Completed

Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours (RAPPORT)

Renal Cell Carcinoma

Australia
Peter MacCallum Cancer Centre, Australia

Completed

MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial (MYPHISMO)

Adenoid Cystic Carcinoma | Colorectal Cancer

Australia
Peter Morris

Completed

Assessing the Role of Inclined Positioning in Acute Respiratory Distress Syndrome Patients Recovery (ARISE)

ARDS, Human

United States
Peter Humaidan

Completed

The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients (GnRHa trigger)

Infertility

Denmark
Peter Humaidan

Completed

Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation

Frozen Embryo Transfer | Pregnancy Loss

Denmark
Peter MacCallum Cancer Centre, Australia

Completed

A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases (FASTRACK)

Cancer

Australia
Peter MacCallum Cancer Centre, Australia

Unknown

Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome

Multiple Myeloma | Myelodysplastic Syndrome | Acute Myeloid Leukaemia

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

Metabolic Phenotypes in Melanoma (MetaMel)

Melanoma

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer (LuCAB)

Metastatic Castration-resistant Prostate Cancer | mCRPC

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary (FAPI-CUP)

Cancer of Unknown Primary Site

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study (PRIME_LUNG)

NSCLC

Australia
Peter Humaidan

Recruiting

The Effect of Clindamycin and a Live Biotherapeutic on the Reproductive Outcomes of IVF Patients With Abnormal Vaginal Microbiota

Infertility, Female | Bacterial Vaginoses

Denmark
Peter MacCallum Cancer Centre, Australia

Recruiting

A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Defects (IMPARP-HRD)

Cancer

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

The Evaluating Multidisciplinary Bone Marrow Failure Care in Bone Marrow Failure and Related Disorders. (EMBRACE)

Aplastic Anemia | Bone Marrow Failure Syndrome

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer (BELLA)

Metastatic Triple Negative Breast Cancer

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer (PALVEN)

Breast Neoplasm Female

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer (LuPARP)

Metastatic Castration Resistant Prostate Cancer (mCRPC)

Australia
Peter MacCallum Cancer Centre, Australia

Completed

COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; (C-SMART)

Cancer | Covid19 | Respiratory Viral Infection

Australia
Peter MacCallum Cancer Centre, Australia

Active, not recruiting

BEACON - ABC in Recurrent Platinum Resistant HGSOC (BEACON)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma

Australia
Peter MacCallum Cancer Centre, Australia

Completed

PRINCE (PSMA-lutetium Radionuclide Therapy and ImmuNotherapy in Prostate CancEr) (PRINCE)

Metastatic Castration Resistant Prostate Cancer

Australia
Peter MacCallum Cancer Centre, Australia

Terminated

Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study (TAILOR)

Cancer

Australia
Peter Humaidan

Completed

The Effect of a Multimodal Lifestyle Program on Male Fertility

Infertility, Male

Denmark
Peter MacCallum Cancer Centre, Australia

Completed

Brentuximab Vedotin and Lenalidomide in Patients With Relapsed/ Refractory T-cell Lymphoma or Hodgkin Lymphoma (EpiBrentlen)

Hodgkin Lymphoma | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral

Australia
Peter MacCallum Cancer Centre, Australia

Completed

A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours (LeY-CAR-T)

Advanced Cancer

Australia
Peter Humaidan

Completed

Is Oxidative Stress in Semen Reduced by Lifestyle Intervention

Oligospermia

Denmark
Peter Brehm GmbH
P.R.I.S.M.A.-CRO

Completed

Combined Prospective and Retrospective Post-Market Follow Up of the 'BPK-S Integration' UC as Primary Implant in the Variant CoCr

Osteoarthritis, Knee | Joint Instability

Belgium

3

Subscribe